![]() |
Volumn 2, Issue 3, 1996, Pages 326-333
|
HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: Lovastatin specifically targets P-glycoprotein-expressing cells
a
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BUCLADESINE;
BUTYRIC ACID;
DOXORUBICIN;
GLYCOPROTEIN P;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
MEVINOLIN;
RETINOIC ACID;
VINCRISTINE;
ARTICLE;
HUMAN;
HUMAN CELL;
NEUROBLASTOMA CELL;
PRIORITY JOURNAL;
BASE SEQUENCE;
BUCLADESINE;
DNA PRIMERS;
ENZYME INHIBITORS;
GENE EXPRESSION REGULATION, ENZYMOLOGIC;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
HYDROXYMETHYLGLUTARYL COA REDUCTASES;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LOVASTATIN;
MOLECULAR SEQUENCE DATA;
NEUROBLASTOMA;
P-GLYCOPROTEIN;
TRETINOIN;
TUMOR CELLS, CULTURED;
|
EID: 0029940090
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/nm0396-326 Document Type: Article |
Times cited : (107)
|
References (7)
|